NDC 68788-8441-03 - telmisartan
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68788-8441
- Requested NDC
- 68788-8441-03
- Package NDCs from labels
- 68788-8441-3, 68788-8441-6, 68788-8441-9, 68788-8441-03
- Manufacturer
- Preferred Pharmaceuticals Inc.
- Effective date
- 2026-09-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| telmisartan - Preferred Pharmaceuticals Inc. | Preferred Pharmaceuticals Inc. | 2026-09-28 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68788-8441-3 | telmisartan | 30 in 1 BOTTLE | TABLET | 30 | 3 | |
| 68788-8441-6 | telmisartan | 60 in 1 BOTTLE | TABLET | 60 | 3 | |
| 68788-8441-9 | telmisartan | 90 in 1 BOTTLE | TABLET | 90 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68788-8441 | TELMISARTAN TABLET [PREFERRED PHARMACEUTICALS INC.] | 2 | Current NDC, 3 package rows | 20240816_f6da5155-9c26-46bb-bc0f-ece4ea21405f.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68788-8441-3 | EA - Each | 68788-8441 | 6f0f705b-8a12-40ff-b0f4-991510f8d70d | 1 | 2023-06-06 |
| 68788-8441-6 | EA - Each | 68788-8441 | bd47b0b6-5024-4c30-8d8a-a3ef90c86d76 | 1 | 2023-06-06 |
| 68788-8441-9 | EA - Each | 68788-8441 | fef65355-7c25-4639-b934-81665ccf1c4b | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| telmisartan | TELMISARTAN | PD-Rx Pharmaceuticals, Inc. | 56a72ddf-c2a2-45ce-91b1-1fcfbff52c10 | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | ANDA205150 282755 U5SYW473RQ |
| Mannitol | MANNITOL | Henry Schein, Inc. | e2444db1-9dfe-451f-a33c-9b00786464d2 | 2026-11-02 | Warnings, Adverse reactions | 3OWL53L36A |
| Telmisartan and Amlodipine | TELMISARTAN AND AMLODIPINE | Alembic Pharmaceuticals Limited | 15b438b4-4874-43f4-a50a-4e6f3e5530ac | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Telmisartan and Amlodipine | TELMISARTAN AND AMLODIPINE | Alembic Pharmaceuticals Inc. | 14f9b590-4c43-439c-a647-9fc2b0fd4d7f | 2026-10-23 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Clear Eyes Triple Relief | POLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDE | Prestige Brands Holdings, Inc. | 1269a1a6-843d-4d08-bb3c-c1f3d2e7080d | 2026-10-23 | Warnings | FZ989GH94E |
| Telmisartan and Hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | 681dfb5c-fc5c-427e-81f6-4b4e934978a2 | 2026-10-16 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| telmisartan | TELMISARTAN | Preferred Pharmaceuticals Inc. | dd2b0604-f887-40d9-9109-dafcc9987e4e | 2026-09-29 | Boxed warning, Warnings, Adverse reactions | ANDA205150 205305 U5SYW473RQ |
| telmisartan | TELMISARTAN | Preferred Pharmaceuticals Inc. | f6da5155-9c26-46bb-bc0f-ece4ea21405f | 2026-09-28 | Boxed warning, Warnings, Adverse reactions | ANDA205150 68788-8441-3 68788-8441-6 68788-8441-9 68788-8441 68788844103 282755 1d39e994-31ef-48a1-bf0e-229117cc9a87 f6da5155-9c26-46bb-bc0f-ece4ea21405f U5SYW473RQ |
| Telmisartan | TELMISARTAN | Preferred Pharmaceuticals Inc. | d45da80a-58c3-4461-adf6-a85531c09eb8 | 2026-09-28 | Boxed warning, Warnings, Adverse reactions | 205304 U5SYW473RQ |
| telmisartan | TELMISARTAN | Preferred Pharmaceuticals Inc. | 963e9245-ec7a-4bf6-9fc0-80f54e3657f0 | 2026-09-28 | Boxed warning, Warnings, Adverse reactions | ANDA205150 205304 U5SYW473RQ |
| REFRESH Classic | POLYVINYL ALCOHOL, POVIDONE | Allergan, Inc. | 31bf1d6c-9719-4060-b6a3-409a2fe7b560 | 2026-09-15 | Warnings | FZ989GH94E |
| Leader Artificial Tears 15 mL | POLYVINYL ALCOHOL, POVIDONE | Cardinal Health | 8cccc589-3a8e-baad-e053-2a95a90ab8c7 | 2026-09-09 | Warnings | FZ989GH94E |
| Telmisartan and Hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | AvKARE | 1b303136-dccd-178b-e063-6394a90a35f8 | 2026-09-08 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| FRESHKOTE PRESERVATIVE FREE LUBRICANT EYE DROPS | POVIDONE, POLYVINYL ALCOHOL SOLUTION | Harrow Eye, LLC | 049e9cc9-0663-53bc-e063-6294a90a2c4f | 2026-09-04 | Warnings | FZ989GH94E |
| Rohto Optic Glow | NAPHAZOLINE HYDROCHLORIDE, POVIDONE, PROPYLENE GLYCOL | The Mentholatum Company | df9c5f7c-96e6-4b2b-b8cb-21a6a3342dff | 2026-08-20 | Warnings | FZ989GH94E |
| Rohto Preservative Free Dry Aid | POVIDONE, PROPYLENE GLYCOL | The Mentholatum Company | f4b1974c-2412-45f6-b79d-88b8a0bcb608 | 2026-08-18 | Warnings | FZ989GH94E |
| Rohto Dry-Aid | POVIDONE, PROPYLENE GLYCOL | The Mentholatum Company | 8ea5c6c9-48f4-406a-a2cb-9280c546d87d | 2026-08-18 | Warnings | FZ989GH94E |
| Caring Mill Lubricant Eye Drops | GLYCERIN, POVIDONE | FSA Store Inc | 2f735cdf-6530-1adf-e063-6394a90ab16a | 2026-08-16 | Warnings | FZ989GH94E |
| Telmisartan | TELMISARTAN | REMEDYREPACK INC. | 57da6ef2-2e86-4e4d-90df-73a2a8cf97f6 | 2026-08-11 | Boxed warning, Warnings, Adverse reactions | 205305 U5SYW473RQ |
| Telmisartan | TELMISARTAN | REMEDYREPACK INC. | 91215664-6e19-4e04-9ae7-ab5664799426 | 2026-07-27 | Boxed warning, Warnings, Adverse reactions | 205305 U5SYW473RQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.